The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.
NYS Entity Status
NYS Filing Date
JULY 28, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2014 - LIBERTY SOURCE PBC.
Around the Web
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
- Mass-transit woes drag Cuomo's approval rating under 50%
By Will Bredderman - Wednesday Jul 12, 2017
After weeks of mass-transit breakdowns, only 46% of New Yorkers approve of Gov. Andrew Cuomo's performance in office, according to the latest Quinnipiac University poll.The survey of 1,137...
To view the full story, click the title link.
- Tina Charles and the Liberty win one for the kids
By Charles Cotton - Wednesday Jul 19, 2017
On a day the Liberty drew 17,443 people to Madison Square Garden — the vast majority of them kids for “Camp Day” — it was only fitting Tina Charles, who herself grew up cheering for the Liberty, would be the one to lead the way. “For sure, I remember being young and watching games and...
- Unfairly overlooked champ gets chance in Barclays spotlight
By George Willis - Friday Oct 13, 2017
Erislandy “The American Dream” Lara will defend his WBA junior middleweight championship against unbeaten Terrell Gausha in the main event of Saturday’s PBC boxing card at Barclays Center. In reality, fans will be treated to three main-event type fights with 154-pound championships at stake. Austin “No Doubt” Trout, the former WBA junior middleweight champion, will...
- Next Liberty coach can’t wait to challenge her mentor
By Brigitte Williams James - Tuesday Oct 17, 2017
Katie Smith, the Liberty’s new head coach, is eagerly anticipating a matchup between the Libs and Bill Laimbeer’s new team. “It will be fun to see him on the other side,” Smith said on a conference call Monday. “I know he’ll want to beat me and I’ll want to beat him.” Smith, 43, played 15...
- Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
By Ben Fidler - Monday Sep 11, 2017
A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]